R-CVP yielded lowest time-to-treatment failure rate in follicular lymphoma Healio Researchers who evaluated three rituximab-containing regimens among patients with follicular lymphoma reported rituximab plus cyclophosphamide, vincristine and prednisone was associated with the lowest time-to-treatment failure rates. The open-label ... |
